<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00723385</url>
  </required_header>
  <id_info>
    <org_study_id>AG0104</org_study_id>
    <secondary_id>5R01AG015982</secondary_id>
    <nct_id>NCT00723385</nct_id>
  </id_info>
  <brief_title>Effects of Vitamin D on Lipids</brief_title>
  <official_title>Effects of Vitamin D on Lipids</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine whether oral vitamin D supplementation in people with
      inadequate vitamin D concentrations will lower LDL-cholesterol and total cholesterol
      concentrations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data from previous trials suggest a protective role of vitamin D in cardiovascular disease. A
      recent meta-analysis of trials with at least 5 years of follow-up of vitamin D
      supplementation concluded that intake of vitamin D supplements may decrease total mortality,
      but that the relationship between baseline vitamin D status, dose of vitamin D supplements,
      and total mortality rates remains to be investigated. An even more recent analysis of vitamin
      D concentrations found that participants with vitamin D deficiency and hypertension were
      about twice as likely as people without hypertension and vitamin D deficiency to have a
      cardiovascular event during the study.

      The main hypothesis to be tested is that normalization of vitamin D levels will lower
      LDL-cholesterol and total cholesterol concentrations in people with inadequate vitamin D
      concentrations as determined by circulating 25-OH vitamin D. Subhypotheses are that
      HDL-cholesterol, triglycerides, lipoprotein(a), hs C-reactive protein and Hemoglobin A1c will
      not be affected, and that cyp3a-metabolized medication levels will decrease with vitamin D
      replacement.

      This is a 12-week randomized double-blind dose titration study of the effects of
      supplementation with 1000-2000 IU vitamin D on lipid and vitamin D concentrations. Dietary
      intake of vitamin D will be estimated by dietary recall questionnaire or analysis of three
      non-consecutive 24-hour dietary intake logs.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>LDL-cholesterol</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vitamin D and metabolite concentrations with supplementation and time course of repletion in deficient or insufficient subjects</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measures of inflammatory markers</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">130</enrollment>
  <condition>Hypercholesterolemia</condition>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo administration for 12 weeks with repeated 25-OH D determinations over 12 weeks, dietary, sunshine questionnaire recording</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin D (1000 or 2000 IU/day)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D (1000 or 2000 IU/day)</intervention_name>
    <description>Dose titration beginning with 1000 IU/day and either remaining at 1000 IU/day for weeks 7-12 if normalized D levels at 6 weeks or increasing to 2000 IU/day for weeks 7-12 if levels not normalized at week 6</description>
    <arm_group_label>Vitamin D</arm_group_label>
    <other_name>cholecalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Administration of placebo for 12 weeks with repeated D measurements</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any medically stable person able to swallow pills

          -  Inadequate vitamin D status at screening visit

        Exclusion Criteria:

          -  Clinical instability of underlying disease process (e.g., recent hospitalization,
             change of dosages of medications within the prior two weeks, or new medications within
             one month)

          -  Recent transfusion

          -  Severe renal failure or dialysis

          -  Hypercalcemia

          -  Malignancy under active treatment

          -  Feeding tube

          -  Intestinal bypass surgery

          -  Inability to swallow tablets
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Janice B. Schwartz, MD,FACC,FAHA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jewish Home, University of California, San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jewish Home</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007 Sep 10;167(16):1730-7. Review.</citation>
    <PMID>17846391</PMID>
  </reference>
  <reference>
    <citation>Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008 Jan 29;117(4):503-11. doi: 10.1161/CIRCULATIONAHA.107.706127. Epub 2008 Jan 7.</citation>
    <PMID>18180395</PMID>
  </reference>
  <results_reference>
    <citation>Kane L, Moore K, LÃ¼tjohann D, Bikle D, Schwartz JB. Vitamin D3 effects on lipids differ in statin and non-statin-treated humans: superiority of free 25-OH D levels in detecting relationships. J Clin Endocrinol Metab. 2013 Nov;98(11):4400-9. doi: 10.1210/jc.2013-1922. Epub 2013 Sep 12.</citation>
    <PMID>24030939</PMID>
  </results_reference>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 24, 2008</study_first_submitted>
  <study_first_submitted_qc>July 24, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 28, 2008</study_first_posted>
  <last_update_submitted>April 7, 2015</last_update_submitted>
  <last_update_submitted_qc>April 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cholesterol</keyword>
  <keyword>LDL-cholesterol</keyword>
  <keyword>cholecalciferol</keyword>
  <keyword>lipids</keyword>
  <keyword>C-reactive protein</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

